The new findings come from the Women's Health Initiative Memory Study of Younger Women (WHIMSY) and were reported by Mark Espeland, Ph.D., of Wake Forest School of Medicine on behalf of the academic research centers involved in the study. The study was funded primarily by the National Institute on Aging (NIA) and the National Heart, Lung, and Blood Institute, components of the National Institutes of Health.
"In contrast to findings in older postmenopausal women, this study tells women that taking these types of estrogen-based hormone therapies for a relatively short period of time in their early postmenopausal years may not put them at increased risk for cognitive decline over the long term," said Susan Resnick, Ph.D., chief of the NIA's Laboratory of Behavioral Neuroscience and a co-author of the study. "Further, it is important to note that we did not find any cognitive benefit after long-term follow-up."
For more on menopause and mental health, see Psychiatric News here
(Image:IdeaStepConceptStock/shutterstock.com)